Pfizer's decision to pull out of its facilities in Sandwich in the UK has triggered a significant amount of hand-wringing over the fate of drug research in the country. Looking for a way to handle the economic fallout, some groups are pointing to the small ventures that are being set up in the wake of a big AstraZeneca close-up as a potential model for the Sandwich site. Switching from a global pharma company to a small enterprise with a handful of employees won't be easy, they warn, but it can be done. Story